https://doi.org/10.4081/monaldi.2023.2675
Tako-Tsubo syndrome in patients with COVID-19: a single centre retrospective case series
Submitted: June 29, 2023
Accepted: August 2, 2023
Published: September 5, 2023
Accepted: August 2, 2023
Abstract Views: 580
PDF_early view: 322
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Growing evidence shows that COVID-19 is associated with an increase in Tako-Tsubo syndrome (TTS) incidence. We collected data from patients hospitalized in our multidisciplinary COVID-19 department who had a diagnosis of TTS during the second and third wave of the pandemic in Italy. We reported four cases of TTS associated with COVID-19. No patient had any classical trigger for TTS except for COVID-19. Mean age was 72 years (67-81) and all patients had a SARS-CoV-2-related interstitial pneumonia confirmed by computed tomography. Typical apical ballooning and transitory reduction in left ventricle (LV) systolic function with a complete recovery before discharge were observed in all patients. The mean LV ejection fraction (LVEF) at TTS onset was 42% (40-48%). ECG showed ST-segment elevation in two cases, while an evolution with negative T waves and QTc prolongation was observed in all patients. Three patients underwent coronary angiography. Two patients had Alzheimer’s disease. The time interval from hospital admission to TTS onset was 4 (2-6) days, and the time interval from COVID-19 symptom onset to TTS diagnosis was 10 (8-12) days. COVID-19 may be a trigger for TTS, though TTS pathophysiology in COVID-19 patients remains unclear, likely due to its multifactorial nature.
World Health Organization. Coronavirus 2019 (COVID 19) situation report. 219. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Kwenandar F, Japar KV, Damay V et al. Coronavirus disease 2019 and cardiovascular system: A narrative review. Int J Cardiol Heart Vasc 2020;29:100557.
DOI: https://doi.org/10.1016/j.ijcha.2020.100557
Nishiga M, Wang DW, Han Y et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020;17:543-58.
Singh S, Desai R, Gandhi Z, et al. Takotsubo syndrome in patients with COVID-19: a systematic review of published cases. SN Compr Clin Med 2020;2:2102-8.
DOI: https://doi.org/10.1007/s42399-020-00557-w
Finsterer J, Stöllberger C. SARS-CoV-2 triggered Takotsubo in 38 patients. J Med Virol 2021;93:1236-8.
DOI: https://doi.org/10.1002/jmv.26581
Lyon AR, Citro R, Schneider B et al. Pathophysiology of Takotsubo syndrome: JACC state-of-the-art review. J Am Coll Cardiol 2021;77:902-21.
DOI: https://doi.org/10.1016/j.jacc.2020.10.060
Ghadri JR, Wittstein IS, Prasad A, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018;39:2032-46.
DOI: https://doi.org/10.1093/eurheartj/ehy076
Di Vece D, Citro R, Cammann VL, et al. Outcomes associated with cardiogenic shock in Takotsubo syndrome. Circulation 2019;139:413-5.
DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.040783
Gili S, Cammann VL, Schlossbauer SA, et al. Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry. Eur Heart J 2019;40:2142-51.
DOI: https://doi.org/10.1093/eurheartj/ehz170
Abe Y, Kondo M, Matsuoka R, et al. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol 2003;41:737-42.
DOI: https://doi.org/10.1016/S0735-1097(02)02925-X
Scantlebury DC, Prasad A. Diagnosis of takotsubo cardiomyopathy. Circ J 2014;78:2129-39.
DOI: https://doi.org/10.1253/circj.CJ-14-0859
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). ESC Scientific Document Group. Eur Heart J 2019;40:237-69.
DOI: https://doi.org/10.1093/eurheartj/ehy856
Zuin M, Mugnai G, Anselmi M, et al. Takotsubo syndrome during COVID-19 pandemic in the Veneto Region, Italy. Viruses 2022;14:1971.
DOI: https://doi.org/10.3390/v14091971
Jabri A, Kalra A, Kumar ,A et al. Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open 2020; 3:e2014780.
DOI: https://doi.org/10.1001/jamanetworkopen.2020.14780
Secco GG, Tarantini G, Mazzarotto P, et al. Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience. Catheter Cardiovasc Interv 2021;97:195-8.
DOI: https://doi.org/10.1002/ccd.28959
Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19 . Eur Heart J Cardiovasc Imaging 2020;21:949-58.
DOI: https://doi.org/10.1093/ehjci/jeaa178
Giustino G, Croft LB, Oates CP, et al. Takotsubo cardiomyopathy in COVID-19. J Am Coll Cardiol 2020;76:62829.
DOI: https://doi.org/10.1016/j.jacc.2020.05.068
Arroyo-Rodríguez C, Victoria-Nandayapa JR, López-Aceves M, et al. Takotsubo syndrome in COVID-19: a case series study. Echocardiography 2022;39:920-34.
DOI: https://doi.org/10.1111/echo.15398
Techasatian W, Nishimura Y, Nagamine et al. Characteristics of Takotsubo cardiomyopathy in patients with COVID-19: systematic scoping review. Am Heart J Plus 2022;13:100092.
DOI: https://doi.org/10.1016/j.ahjo.2022.100092
Zuin M, Dal Santo P, Picariello C, et al. Takotsubo cardiomyopathy in an elderly woman with Alzheimer's disease: a rare association. Case Report and mini-review of the literature. J Am Geriatr Soc 2016;64:916-7.
DOI: https://doi.org/10.1111/jgs.14071
Ito M, Fukui K, Miyamoto N, et al. Takotsubo cardiomyopathy in a bedridden patient with dementia and communication difficulties due to Alzheimer's disease. J Rural Med 2022;17:89-93.
DOI: https://doi.org/10.2185/jrm.2021-055
Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med 2020;383:2255-73.
DOI: https://doi.org/10.1056/NEJMra2026131
Staedtke V Papadopoulos N, Kinzler KW, et al. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature 2018;564:273-7.
DOI: https://doi.org/10.1038/s41586-018-0774-y
Babapoor-Farrokhran S, Gill D, Walker J, et al. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020;253:117723.
DOI: https://doi.org/10.1016/j.lfs.2020.117723
Dai K, Shiode N, Nakano Y. Disaster-related Takotsubo syndrome - A lesson from the great East Japan earthquake and tsunami on March 11, 2011. Circ J 2021;85:1840-1.
DOI: https://doi.org/10.1253/circj.CJ-21-0532
Sato M, Fujita S, Saito A, et al. Increased incidence of transient left ventricular apical ballooning (so-called ’Takotsubo’ cardiomyopathy) after the mid-Niigata Prefecture earthquake. Circ J 2006;70:947-53.
DOI: https://doi.org/10.1253/circj.70.947
Meyer P, Degrauwe S, Van Delden C ,et al. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J 2020;41:1860.
DOI: https://doi.org/10.1093/eurheartj/ehaa306
Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 2020;395:912-20.
DOI: https://doi.org/10.1016/S0140-6736(20)30460-8
Salari N, Hosseinian-Far A, Jalali R, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health 2020;16:57.
DOI: https://doi.org/10.1186/s12992-020-00589-w
Nishiga M, Wang DW, Han Y, et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 202017: 543-58.
DOI: https://doi.org/10.1038/s41569-020-0413-9
Okura H. Update of takotsubo syndrome in the era of COVID-19. J Cardiol 2021;77:361-9.
DOI: https://doi.org/10.1016/j.jjcc.2020.10.004
Yin J, Wang S, Liu Y, et al. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation 2021;28:e12718.
DOI: https://doi.org/10.1111/micc.12718
Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res 2021;117:2705-29.
DOI: https://doi.org/10.1093/cvr/cvab298
How to Cite
Alonzo, Alessandro, Stefania Angela Di Fusco, Lorenzo Castello, Andrea Matteucci, Antonella Spinelli, Gaetano Marino, Stefano Aquilani, Giuseppe Imperoli, and Furio Colivicchi. 2023. “Tako-Tsubo Syndrome in Patients With COVID-19: A Single Centre Retrospective Case Series”. Monaldi Archives for Chest Disease, September. https://doi.org/10.4081/monaldi.2023.2675.
Copyright (c) 2023 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
